Clinical Trial Update: Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of DNN.22.17.036 in male pattern hair loss (alopecia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Male Pattern Hair Loss

Drugs mentioned

• DNN.22.17.036

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Alopecia | Phase 4 | Status: UNKNOWN